Key result
Atorvastatin added to antiarrhythmic therapy is linked to improved HRV and a ~33% increase in RMSSD.
Why the study?
The effects of atorvastatin therapy on heart rate variability in patients with ischemic heart disease and paroxysmal atrial fibrillation were evaluated to understand its impact on autonomic balance.
Does atorvastatin improve heart rate variability in patients with ischemic heart disease and paroxysmal atrial fibrillation?
Does atorvastatin improve heart rate variability in patients with ischemic heart disease and paroxysmal atrial fibrillation?
Atorvastatin 10 mg/day improves autonomic balance as measured by heart rate variability in patients with ischemic heart disease and paroxysmal atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Atorvastatin may improve HRV indices in IHD with paroxysmal AF; leaves open any clinical role beyond standard therapy.
Aim. To evaluate the heart rate variability (HRV) in patients with ischemic heart disease (IHD) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods . 60 patients with IHD and paroxysmal AF were included in the study. Patients were divided into two groups – control group (basic antiarrhythmic therapy) and second group (basic antiarrhythmic therapy and atorvastatin (Liptonorm, Pharmstandart, Russia) 10mg/day). HRV was compared before and after 3 months of therapy in both groups. Results. Liptonorm significantly improved HRV indices in comparison with basic therapy alone: RMSSD increased on 33% (р <0,02), total power (TP) of spectrum on 28% (р <0,03) and high frequency (HF) component on 53 % (р <0,01). Conclusion. Liptonorm therapy improves autonomic balance in patients with IHD and paroxysmal AF.
No takes yet. Share an insight, caveat, or question.
Kozlova et al. (2008) studied Ischemic heart disease and paroxysmal atrial fibrillation (n=60). Atorvastatin vs. Basic antiarrhythmic therapy alone was evaluated on Heart rate variability (HRV) indices (33% increase in RMSSD, 28% increase in TP, 53% increase in HF, p=<0.02 for RMSSD, <0.03 for TP, <0.01 for HF). Atorvastatin /day added to basic antiarrhythmic therapy improved heart rate variability, increasing RMSSD by 33% and the high frequency component by 53%.
Synapse has enriched 10 related papers. Consider them for comparative context: